Mitral annular calcification in untreated chronic renal failure

Area of Science:

• Nephrology
• Cardiology
• Echocardiography

Background:

• End-stage chronic renal failure (CRF) patients often present with cardiovascular complications.
• The prevalence and impact of mitral annular calcification (MAC) in untreated CRF require further investigation.

Purpose of the Study:

• To prospectively evaluate clinical, biochemical, radiological, and echocardiographic findings in 50 untreated end-stage CRF patients.
• To compare characteristics and outcomes between CRF patients with and without MAC.

Main Methods:

• Prospective evaluation of 50 untreated end-stage CRF patients.
• Clinical assessment, biochemical tests, radiological imaging, and echocardiography (echo).
• Comparison of patients with MAC (Group I) versus those without MAC (Group II).

Main Results:

• Congestive cardiac failure (CCF) diagnosed clinically in 24%, but low ejection fraction on echo in only 16%.
• Mitral annular calcification (MAC) detected in 26% of patients.
• MAC was associated with higher rates of diabetes (61.5% vs 35.1%, P<0.05) and conduction disturbances (30.7% vs 5.4%, P=0.05).
• Cardiac chamber dilatation was common, but cardiac function parameters were mostly normal.
• Mitral regurgitation due to MAC was not hemodynamically significant.

Conclusions:

• Mitral annular calcification (MAC) is prevalent in end-stage chronic renal failure (CRF) and associated with diabetes and conduction disturbances.
• Despite MAC presence, significant cardiac dysfunction or hemodynamically relevant mitral regurgitation was uncommon in this cohort.
• Further research into the specific mechanisms and long-term implications of MAC in CRF is warranted.